ABC: Abcam plc - Summary | Jitta
Notice
Stock data is unavailable or the company’s delisted.
Price
£12.26
Loss Chance
47.5%
5.76JITTA SCORE
550.61%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (61)
Recent Business Performance (61)
Financial Strength (95)
Return to Shareholders (29)
Competitive Advantage (43)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Revenue and EarningEarning decline from 2018-2021
Operating MarginInconsistent
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.76
550.61%
1.95
101.42%
3.14
125.88%
Biotechnology
2.46
100.00%
0.25
100.00%
4.62
122.74%
COMPANY DESCRIPTION
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.